Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G/A for enGene Holdings Inc. Common Shares, no par value per share (ENGN).
- Disclosed ownership: 1.8%.
- Date of event: 27 Jan 2025.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 1.8% ownership in enGene Holdings Inc. Common Shares, no par value per share (ENGN) on 27 Jan 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 1% | 505,835 | 0 | 505,835 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 1% | 505,835 | 0 | 505,835 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 0.7% | 383,352 | 0 | 383,352 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 0.7% | 383,352 | 0 | 383,352 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 0.1% | 43,786 | 0 | 43,786 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 0.1% | 43,786 | 0 | 43,786 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 1.7% | 889,187 | 0 | 889,187 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 1.8% | 945,402 | 0 | 945,402 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 1.8% | 945,402 | 0 | 945,402 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 1.8% | 945,402 | 0 | 945,402 | /s/ Mark N. Lampert | Mark N. Lampert |